Cargando…
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo
BACKGROUND: Chemotherapy in cancer patients can be associated with serious short- and long-term adverse neurological effects, such as leukoencephalopathy and cognitive impairment, even when therapy is delivered systemically. The underlying cellular basis for these adverse effects is poorly understoo...
Autores principales: | Dietrich, Joerg, Han, Ruolan, Yang, Yin, Mayer-Pröschel, Margot, Noble, Mark |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2000477/ https://www.ncbi.nlm.nih.gov/pubmed/17125495 http://dx.doi.org/10.1186/jbiol50 |
Ejemplares similares
-
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
por: Han, Ruolan, et al.
Publicado: (2008) -
Stochastic modeling of oligodendrocyte generation in cell culture: model validation with time-lapse data
por: Hyrien, Ollivier, et al.
Publicado: (2006) -
Expression of the Human Herpesvirus 6A Latency-Associated Transcript U94A Disrupts Human Oligodendrocyte Progenitor Migration
por: Campbell, Andrew, et al.
Publicado: (2017) -
Pericytes Stimulate Oligodendrocyte Progenitor Cell Differentiation during CNS Remyelination
por: De La Fuente, Alerie Guzman, et al.
Publicado: (2017) -
High-efficiency pharmacogenetic ablation of oligodendrocyte progenitor cells in the adult mouse CNS
por: Xing, Yao Lulu, et al.
Publicado: (2023)